designtx.com (DSGN) - Utang marang Ekuitas

DSGN (Design Therapeutics, Inc.) - tandha merek perusahaan

Design Therapeutics (DSGN) management aims to correct genetic malfunctions by regulating gene function, guided by strict ethical principles. The brand is highly regarded in medicine for developing molecules to treat complex neurological pathologies. Current developments in the field of hereditary diseases confirm the firm's technological growth. The market trend on GURU.Markets shows that the total debt-to-equity ratio is 0.01.

DSGN: Total Utang marang Modal designtx.com 04.07.2022 - 29.10.2026

Rincian metrik komprehensif lan analitis Design Corp (DSGN)

- rega lan prakiraan konsensus rega:
Rega saham Design Therapeutics, Inc.|DSGN - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Nilai pasar Design Therapeutics|DSGN - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Design Therapeutics|DSGN - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku designtx.com|DSGN - Total Aset Bisnis
- data utang lan likuiditas:
Total Utang marang Modal Design Therapeutics|DSGN - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Design Therapeutics|DSGN - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Design Therapeutics|DSGN - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Design Therapeutics
Analisis dhasar perusahaan:Design Therapeutics, Inc. - DSGN
Sampel barang Design Therapeutics

Design Therapeutics focuses on high-risk GeneTAC developments for the treatment of neurodegeneration. By analyzing the company's leverage history, an investor assesses the proportion of debt to equity. This metric measures the balance sheet structure's dependence on external financing and its sensitivity to borrowing costs. Low debt levels currently offset the absence of a commercial product, ensuring the financial sustainability of R&D until clinical trials are completed.

Pesaing utama

Total Utang marang Modal tempus.com (TEM)|Rasio Utang marang Ekuitas QGEN|Utang marang Ekuitas Ionis Pharma IONS|Rasio Utang marang Ekuitas Repligen Inc. (RGEN)|Total Utang marang Modal RNA (Avidity Biosciences)|Total Utang marang Modal crisprtx.com CRSP|GeneDx (WGS) - Total Utang marang Modal|RARE - Rasio Utang marang Ekuitas|Total Utang marang Modal BEAM|SRPT (Sarepta Corp) - Utang marang Modal|TWST: Utang marang Ekuitas|Koefisien Total Utang marang Modal 10xgenomics.com|NTLA (Intellia Therapeutics, Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal Stoke Therapeutics Inc (STOK)|BLFS (BioLife Corp) - Total Utang marang Modal|Wave Pharma - Rasio Utang marang Modal|Maze Therapeutics Inc (MAZE) - Utang marang Ekuitas|sionnatx.com (SION) - Rasio Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Prime Medicine PRME|Rasio Kabeh Utang marang Dana Pribadi Taysha Gene Therapies Inc|uniQure Corp (QURE) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal MeiraGTx Corp|REGENXBIO Inc. (RGNX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi solidbio.com (SLDB)|OCGN: Total Utang marang Modal|Pacific Biosciences of California, Inc. - Utang marang Modal|Utang marang Ekuitas Benitec (BNTC)|RCKT - Rasio Kabeh Utang marang Dana Pribadi|FDMT: Total Utang marang Modal|LXEO (Lexeo Therapeutics, Inc.) - Total Utang marang Modal|Utang marang Ekuitas Korro Bio Inc. KRRO|Utang Agregat marang Ekuitas Editas Medicine Inc|Silence Therapeutics Inc. - Total Utang marang Modal|Utang marang Modal proqr.com PRQR|Rasio Total Utang marang Ekuitas CDXS (Codexis)|SGMO - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Nautilus Biotechnology Inc NAUT|MGX - Utang Agregat marang Modal|Precision BioSciences, Inc. - Total Utang marang Modal|Generation Bio (GBIO) - Koefisien Total Utang marang Modal|Total Utang marang Modal BOLD|Rasio Total Utang marang Ekuitas XCUR|IMNN (Imunon, Inc.) - Utang marang Ekuitas|Koefisien Total Utang marang Modal phiopharma.com (PHIO)|MBIO - Total Utang marang Modal|TransCode Therapeutics Inc. - Rasio Utang marang Ekuitas|Utang marang Ekuitas BNGO (Bionano)|APDN - Koefisien Total Utang marang Modal|Total Utang marang Modal BLUE (bluebird bio)|IPA (ImmunoPrecise Antibodies Ltd.) - Rasio Utang marang Modal|Utang marang Ekuitas Omega (OMGA)|Rasio Utang marang Ekuitas Singular Genomics Corp|Total Utang marang Modal Regulus Therapeutics RGLS|Rasio Utang marang Ekuitas SYRS (syros.com)|TBIO - Utang marang Ekuitas|Rasio Utang marang Ekuitas TRACON Pharmaceuticals Inc. TCON|Unity Bio - Total Utang marang Modal